There are 112 papers on interleukin-1β in aging research: 20 trials and 16 observational studies in people, 56 in animals, 6 in cells, 13 reviews. The newest story, Oct 4, 2026: “Plasma CXCL10 links to higher stroke risk in older adults”.
Combined aerobic and resistance training decreases interleukin-1β in rats (compared with diabetic control in type 2 diabetic rats) (P=0.019).
“Chronic implementation of combined training significantly downregulated final weight (P=0.033), protein levels of NLRP3, Caspase-1, and IL-1β (P=0.03, 0.001 and 0.019, respectively) in the cardiac tissue”
Animalscompared with diabetic control in type 2 diabetic ratsmyocardiumfive sessions/week8 weeksmalesn = 8
Alpha-mangostin decreases interleukin-1β in chickens.
“Moreover, α-Ma at 120 mg/kg specifically lowered the concentration of the pro-inflammatory cytokine interleukin-1β in both serum and uterine tissue (p < 0.05).”
Astaxanthin decreases interleukin-1β in response to maximal exercise.
“Univariate analysis found no significant treatment x time effects for IL-1β, IL-6, and IL-8 pro-inflammatory cytokines, the anti-inflammatory cytokine IL-4, or white cell stimulator Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF).”
Human trialin response to maximal exerciseserumfour weeksmalesn = 20
Blackcurrant anthocyanins decrease interleukin-1β in humans (dose and time dependent effect in a randomized placebo-controlled trial) (p < 0.05; dose and time dependent).
“Plasma interleukin-1β (IL-1β) was significantly reduced in a dose and time dependent manner (p < 0.05).”
Human trialdose and time dependent effect in a randomized placebo-controlled trialanthocyanin extract392 mg/day and 784 mg/daysix monthsfemalesn = 38
Berberine showed no clear effect on interleukin-1β in patients with metabolic syndrome and related disorders (SMD = -0.81, 95% CI -1.80, 0.17, p = 0.11).
“However, it did not affect the level of interleukin 1β (IL-1β) [SMD = - 0.81, 95% CI - 1.80, 0.17, p = 0.11].”
Reviewin patients with metabolic syndrome and related disordersn = 4,616
Remote ischemic preconditioning decreases interleukin-1β in humans (serum concentrations compared with control group).
“remote ischemic preconditioning markedly decreased the serum concentrations of the interleukin-1β (IL-1β), tumor necrosis factor-α (TNF-α), and S100B proteins compared with the control group (P < .001).”
Human trialserum concentrations compared with control groupstatic pressure of 200 mm Hg for 3 ischemia cycles of 5 minutes each
“the nucleotide-binding oligomerization domain (NOD)-like receptor family pyrin domain-containing protein 3 (NLRP3) inflammasome is the most characterized protein complex, whose activation leads to increased release of downstream effectors (interleukin (IL)-1β, IL-18, IL-6)”
Each 1-standard deviation higher CXCL10 was linked to 20% greater stroke risk over a median follow-up of 14 years.Each 1-standard deviation higher CXCL10 was linked to 20% greater stroke risk over a median follow-up of 14 years.
In ovariectomized rats, inhibiting TRPM3 with naringenin restored serotonin signaling and dendritic arborization while reducing neuroinflammation and depressive-like…In ovariectomized rats, inhibiting TRPM3 with naringenin restored serotonin signaling and dendritic arborization while reducing neuroinflammation and depressive-like deficits.